Testing effectiveness (Phase 2)Study completedNCT03866967What this trial is testingAnti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 130
Testing effectiveness (Phase 2)Ended earlyNCT01313390What this trial is testingEverolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Not applicableActive Not RecruitingNCT06612697What this trial is testingLong-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy AloneWho this might be right forNasopharyngeal Carcinoma (NPC)OncologyRadiology Taichung Veterans General Hospital 262
Testing effectiveness (Phase 2)UnknownNCT05232552What this trial is testingStudy of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Zhejiang Cancer Hospital 37
Testing effectiveness (Phase 2)Study completedNCT00095901What this trial is testingCapecitabine For Nasopharyngeal CancerWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 3
Large-scale testing (Phase 3)UnknownNCT02958111What this trial is testingSingle-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 406
Testing effectiveness (Phase 2)Study completedNCT01349933What this trial is testingAkt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the Nasopharynx National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00002476What this trial is testingRadiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Cancer Research UK
Early research (Phase 1)UnknownNCT03282617What this trial is testingDendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Cancer National University Hospital, Singapore 55
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Large-scale testing (Phase 3)UnknownNCT02633176What this trial is testingCisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Sun Yat-sen University 120
Early research (Phase 1)Study completedNCT03188497What this trial is testingDose Escalation of Lobaplatin Concurrent With IMRT for the Treatment of NPC: A Phase I Clinical TrialWho this might be right forAcute Toxic EffectsTumor Responses Fifth Affiliated Hospital, Sun Yat-Sen University 17
Large-scale testing (Phase 3)Looking for participantsNCT07340515What this trial is testingProton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III TrialWho this might be right forNasopharyngeal Carcinoma (NPC) Man Hu 300
Large-scale testing (Phase 3)UnknownNCT00022373What this trial is testingIseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerOral Complications of Radiation TherapyRadiation Toxicity National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT01096381What this trial is testingPotential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid TumorWho this might be right forBreast CancerCardiovascular ComplicationsColorectal Cancer+6 more Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT06811844What this trial is testingTwo-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCWho this might be right forNasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)UnknownNCT04627961What this trial is testingA Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forMetastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal Carcinoma National University Hospital, Singapore 33
Testing effectiveness (Phase 2)UnknownNCT01612286What this trial is testingEndostar Combination With Chemotherapy for the Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Zhejiang Cancer Hospital 30